Our Research Interests

• Dr. Clint Allen is an Otolaryngologist whose basic and clinical research focuses on understanding dysfunctional immune responses within human papillomavirus positive and negative head and neck cancers as well as recurrent respiratory papillomatosis and how anti-tumor immunity can be therapeutically enhanced to improve clinical outcomes for patients with these disorders
• Dr. Andrew Blakely is a surgical oncologist specializing in peritoneal surface and retroperitoneal malignancies. A primary focus of his research is to develop novel treatment approaches and modalities to improve pre-operative treatment of peritoneal carcinomatosis.
• Dr. Jonathan Hernandez is a surgical oncologist and hepatopancreatobiliary surgeon whose research efforts focus on elucidating the mechanisms through which tumor cells coopt the microenvironment of distant organs to form life-threatening metastases in order to interrupt this process prior to its completion.
• Dr. Nyall London is an otolaryngology surgeon-scientist specialized in open and endoscopic resection of sinonasal and skull base malignancies. His research laboratory utilizes a variety of in vitro and in vivo approaches to identify critical genes that drive sinonasal tumor development, determine their mechanism of action, and assess their potential as therapeutic targets. We are actively developing a series of clinical trials to improve treatment effectiveness and survival in patients with sinonasal and skull base cancers.
• Dr. Naris Nilubol is a surgeon-scientist specialized in endocrine oncology surgery and clinical research involving thyroid, parathyroid, adrenal, and neuroendocrine tumors. His laboratory research focus includes the identification of novel targeted therapeutics in endocrine cancers and novel cancer drug delivery methods by targeting tumor microenvironment.
• Dr. Samira Sadowski specializes in endocrine surgery and her research focuses on the identification of diagnostic and prognostic markers for endocrine tumors and developing new therapies for such tumors.
• Dr. Martha Zeiger is an internationally renowned endocrine surgeon and scientist who has been a leader in developing molecular diagnostics for thyroid cancer. Dr. Zeiger directs the CCR Office of Surgeon-Scientist Career Development, Office of the Clinical Director, where she leads a team studying and designing future pathways for the professional development of surgeon-scientists.  Her research interests focus on TERT gene expression regulation, molecular marker diagnostic panel development and molecular biological aspects of thyroid cancer development.